Patent ID: 9119776
Filing Date: 2015-09-01
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition for application to the oral mucosa comprising: a water soluble matrix comprising an effective amount of a pharmaceutically active agent and an absorption enhancer having an HLB of about 8 to about 16, wherein the matrix is a film; the absorption enhancer is one or more sucrose fatty acid esters; and the pharmaceutically active agent is an agent for the treatment of pain in a patient and is present in an amount which is effective for treating said pain, wherein the agent for the treatment of pain is selected from the group consisting of fentanyl, hydromorphone, morphine, sufentanyl, methadone, buprenorphine, Acetaminophen, Ibuprofen, ketoprofen, indomethacin, aspirin (low dose for cardiovascular), naproxen sodium, ketorolac, diclofenac, meloxicam, and piroxicam.